| abstract |
Disclosed are methods for treating inflammatory lung disease by administering an effective amount of one or more pharmaceutical agents to a patient. Examples of pharmaceuticals to be administered include antibiotics, steroids, NSAIDs, DMARDs, growth factor receptor inhibitors, PI3K inhibitors, neurotransmitter receptor inhibitors, or protease inhibitors. The dose administered is effective to suppress or prevent the onset, progression, or recurrence of the disease, including the progression of the established disease. The medicament is administered to a patient determined to have the disease in an amount effective to inhibit or prevent disease activity. The medicament is administered using a transtracheal, transbronchial, or transvascular drug delivery catheter. The medicament can be administered to the patient's lung tissue to suppress the response in response to bronchial thermoplasty either before, during, or after bronchial thermoplasty. |